Skip to main content

NCT00270166 - A Placebo-Controlled Study on the Effect of Epoetin Alfa in Patients With Malignancy Receiving Chemotherapy

A Placebo-Controlled Study on the Effect of Epoetin Alfa in Patients With Malignancy Receiving Chemotherapy

Data Request Dashboard

Operations

No data requests found. Click here to generate a new one.


Primary Citation

Trial has yet to be published


Data Specification

Not Available


Annotated CRF

Not Available

Product Info

Generic Name
Epoetin alfa
Product Name
PROCRIT®
Therapeutic Area
Blood and Lymph Conditions
Enrollment
201
% Female
N/A
% White
N/A
Product Class
Colony-Stimulating Factors
Sponsor Protocol Number
CR005923 (EPO-INT-3)
Data Holder
Johnson & Johnson
Condition Studied
Anemia, Neoplasms
Mean/Median Age (Years)
N/A

Supporting Documentation

Data Definition Specification Available
Annotated Case Report Form Available
Clinical Study Report
Collected Datasets
Data Definition Specification
Protocol with Amendments
Statistical Analysis Plan
Study Phase 
3

Disclaimer

Clinical study data provided through this site do not replace the official labeling of a given drug product, which presents benefits and risks of the product for approved use(s). Before prescribing any product, health care professionals should consult the current prescribing information approved in their country. Patients seeking information may consult with their health care professional about the product, for which health authority approved written patient information may be available.